Fortrea Holdings Inc. (FTRE) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US34965K1079
Fortrea Holdings Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.72 bn USD |
| Gross profit | 503.80 m USD |
| Operating income | -872.60 m USD |
| EBIT | -983.00 m USD |
| Net income | -986.20 m USD |
| Diluted EPS – continuing operations | -10.81 USD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
More stocks
- Zhejiang Chengchang Technology Co. Ltd. (001270.SZ)
- Shanghai Kingstar Winning Software (300253.SZ)
- Yunnan Shennong Agricultural Industry Group Co Ltd (605296.SS)
- Hubei DOTI Micro Technology Co. Ltd. (301183.SZ)
- MLS Co Ltd (002745.SZ)
- Suzhou Nanomicro Technology Co Ltd (688690.SS)
- Shandong Buchang Pharmaceuticals Co Ltd (603858.SS)
- LiveRamp Holdings, Inc. (RAMP)
- Mitsui E&S Co Ltd (7003.T)
- Dermapharm Holding (DMP.DE)
- Anhui XDLK Microsystem Corp. Ltd. A (688582.SS)
- NETLIST INC (NLST)
Not investment advice. All data without warranty, price as of 26.10.2026. Details in the risk notice.